Alchemab Therapeutics
Drug Discovery
- Website
- https://www.alchemab.com/
- Membership category
- Corporate
The Office Group, East Side, Office 1.02, London, N1C 4AX, United Kingdom
Alchemab Therapeutics at a glance
Pioneering the next generation of antibody therapeutics for hard-to-treat diseases
About Alchemab Therapeutics
Alchemab has developed a highly differentiated platform which enables the identification of novel drug targets and therapeutics by analysis of patient antibody repertoires. The platform uses well-defined patient samples, deep B cell sequencing, and computational analysis to identify convergent protective antibody responses among individuals that are susceptible but resilient to specific diseases.
Alchemab is building a broad pipeline of protective therapeutics for hard-to-treat diseases, with an initial focus on neurodegenerative conditions and oncology. The highly specialized patient samples that power Alchemab’s platform are made available through valued partnerships and collaborations with patient representative groups, biobanks, industry partners, and academic institutions.